Active/Completed Active GrantsCompleted Grants PI Name Sort descending PI Organization Title Grant Number Program Official Shelby, Rebecca A Duke University United States Improving outcomes for women experiencing premature or early menopause after cancer: development and pilot testing of a novel intervention 1R21CA301298-01 Goli Samimi, Ph.D., M.P.H. Shiozawa, Yusuke Wake Forest University Health Sciences United States Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy 5R21CA297068-02 Rachel Altshuler, Ph.D. Shiozawa, Yusuke Wake Forest University Health Sciences United States Contribution of cutaneous neuro-immune interactions to chemotherapy-induced peripheral neuropathy 5R21CA297068-02 Rachel Altshuler, Ph.D. Siskind, Leah J University Of Louisville United States Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease 1R01CA305985-01 Marjorie Perloff, M.D. Siskind, Leah J University Of Louisville United States Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease 1R01CA305985-01 Marjorie Perloff, M.D. Sohl, Stephanie Jean Wake Forest University Health Sciences United States REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) 5R01CA266995-04 Goli Samimi, Ph.D., M.P.H. Sohl, Stephanie Jean Wake Forest University Health Sciences United States REmotely-delivered Supportive Programs for Improving surgical pain and disTrEss (RESPITE) 5R01CA266995-04 Goli Samimi, Ph.D., M.P.H. Spiegel, Brennan Cedars-Sinai Medical Center United States Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-05 Rachel Altshuler, Ph.D. Spiegel, Brennan Cedars-Sinai Medical Center United States Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes 5R01CA252211-05 Rachel Altshuler, Ph.D. Staff, Nathan P Mayo Clinic Rochester United States Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-04 Rachel Altshuler, Ph.D. Staff, Nathan P Mayo Clinic Rochester United States Investigating the role of MAP2 in chemotherapy-induced peripheral neurotoxicity 5R01CA275870-04 Rachel Altshuler, Ph.D. Upshaw, Jenica Beth Israel Deaconess Medical Center United States A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure 1R37CA300969-01 Eileen Dimond, R.N., M.S. Upshaw, Jenica Beth Israel Deaconess Medical Center United States A randomized trial of cardioprotective strategies in newly diagnosed diffuse large B-cell lymphoma and pre-existing cardiomyopathy or prior anthracycline exposure 1R37CA300969-01 Eileen Dimond, R.N., M.S. Valdimarsdottir, Heiddis Icahn School Of Medicine At Mount Sinai United States Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation 5R01CA260961-04 Marjorie Perloff, M.D. Valdimarsdottir, Heiddis Icahn School Of Medicine At Mount Sinai United States Systematic Light Exposure Effects on Circadian Rhythms Entrainment, Inflammation, Neutropenic Fever and Symptom Burden among Multiple Myeloma Patients undergoing Autologous Stem Cell Transplantation 5R01CA260961-04 Marjorie Perloff, M.D. Pagination « First First page ‹ Previous Previous page … 12 13 14 15 Next › Next page Last » Last page
